Clincosm LogoSign in Get a demo

peripheral neuropathic pain

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral Neuropathic Pain Trial in Beijing (HSK16149 40mg BID)

Active, not recruiting
  • Peripheral Neuropathic Pain
  • HSK16149 40mg BID
  • Beijing, Beijing, China
    Peking University First Hospital
May 24, 2023

High-concentration Capsaicin Desensitization in Peripheral

Not yet recruiting
  • Peripheral Neuropathic Pain
  • Capsaicin 8%
  • (no location specified)
Apr 18, 2023

Neuropathic Pain Associated With Diabetic Peripheral Neuropathy, Peripheral Neuropathic Pain, Diabetes Trial in Worldwide

Completed
  • Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
  • +2 more
  • Chocen, Czechia
  • +29 more
Dec 14, 2022

Peripheral Neuropathic Pain Trial in Uppsala (ACD440 Gel 14mg/g, Placebo Gel)

Recruiting
  • Peripheral Neuropathic Pain
  • ACD440 Gel 14mg/g
  • Placebo Gel
  • Uppsala, Sweden
    Akademiska sjukhuset
Jun 21, 2022

Peripheral Neuropathic Pain, Radiculopathy, Lower Back Pain Trial in Oslo, Uppsala (Burst SCS (Abbott Proclaim IPG and single

Recruiting
  • Peripheral Neuropathic Pain
  • +2 more
  • Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10)
  • Oslo, Norway
  • +1 more
Sep 6, 2021

NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under

Completed
Has Results
  • Peripheral Neuropathic Pain
  • No intervention. Non-interventional study
  • (no location specified)
Jan 26, 2021

Neuralgia, Peripheral Neuropathic Pain Trial in Toronto (Bupivacaine, Depo-Medrol Injectable Product, Saline (Sodium Chloride)

Completed
  • Neuralgia
  • Peripheral Neuropathic Pain
  • Toronto, Ontario, Canada
    Toronto Western Hospital
Mar 23, 2020

Associated With Chemotherapy-Induced Nerve Damage

Terminated
  • Peripheral Neuropathic Pain
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 4, 2019

    Peripheral Neuropathic Pain Trial in Jeonju (YHD1119 300mg)

    Completed
    • Peripheral Neuropathic Pain
    • YHD1119 300mg
    • Jeonju, Korea, Republic of
      Chonbuk National University Hospital
    Jan 14, 2019

    Peripheral Neuropathic Pain Trial in Seoul (YHD1119, Lyrica)

    Completed
    • Peripheral Neuropathic Pain
    • Seoul, Korea, Republic of
      Yong Chul Kim
    Jan 14, 2019

    Peripheral Neuropathic Pain Trial in Haifa, Holon (The Reprieve system)

    Completed
    • Peripheral Neuropathic Pain
    • The Reprieve system
    • Haifa, Israel
    • +1 more
    Apr 10, 2018

    Neuropathic Traumatic Pain, Pain NRS = 4, Peripheral Neuropathic Pain Trial in Clermont-Ferrand (Zarontin® (ethosuximide) and

    Completed
    • Neuropathic Traumatic Pain
    • +3 more
    • Zarontin® (ethosuximide) and Stodal®
    • Clermont-Ferrand, France
      CHU de Clermont-Ferrand
    Apr 3, 2018

    Observation of the Use of QUTENZA™ in Standard Clinical Practice

    Completed
    • Peripheral Neuropathic Pain
    • Qutenza exposure
    • Graz, Austria
    • +49 more
    Oct 3, 2014

    Peripheral Neuropathic Pain, Nociceptive Pain Trial in London (AZD3161, Lidocaine, AZD3161 Placebo)

    Completed
    • Peripheral Neuropathic Pain
    • Nociceptive Pain
    • London, United Kingdom
      Research Site
    Apr 11, 2011